Hosted on MSN6d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
Inquirer on MSN3d
World’s first anti-depression nasal spray receives FDA approvalThe US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...
Irish Examiner on MSN19h
Nasal irrigation: Breathe easy by flushing out your nasal cavityNasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
The money will pay for efforts to prevent and treat opioid addiction, or fund services that help people in recovery.
In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...
The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback